Search

everythinglearnresearchcommunity

for

Search:↓

2-deoxy-D-ribose gel may help regrow hair in cases of hair loss.

Sebaceous glands in male pattern hair loss patients have more lobules and might cause early hair growth phase shifts.

Testosterone therapy can help improve sexual desire and function in postmenopausal women but may cause side effects and is not FDA-approved for this use.

The topical treatment with caffeine and Procapil 3% improved male pattern hair loss and was well tolerated after 12 weeks.

Sex hormones affect hair and feather growth and may help manage alopecia and hormone-dependent cancers.

Canrenone effectively reduced hair growth and testosterone levels in women with excessive hairiness.

Baldness caused by male hormones in female-to-male transsexuals doesn't increase the risk of heart disease.

Higher dihydrotestosterone may be linked to more inflammation in COVID-19 patients with low testosterone.

Women with androgenic alopecia are more likely to have polycystic ovaries and higher androgen levels, which may indicate PCOS.

Severe and early hair loss may indicate a higher risk of heart disease.

Steroid Sulfatase inhibitors show promise in treating hormone-dependent disorders like cancers, hair loss, and acne, with 667COUMATE being a potential candidate for breast cancer treatment trials.

Flutamide works better than finasteride for hirsutism, and combining both is slightly better but not much.

Severe hair loss significantly worsens quality of life.

Conflicting findings in androgenic alopecia are likely due to biopsy location, hair diameter diversity, and hair follicle miniaturization.

Early hair loss in men may signal broader health issues similar to PCOS in women.

Researchers found new potential but less potent rat enzyme inhibitors using a 3D model.

People with hair loss have worse cholesterol levels, possibly linking hair loss to heart problems.

LY320236 is a strong blocker of two enzymes that change testosterone into dihydrotestosterone and might help treat conditions related to male hormones.

Using anabolic androgenic steroids can cause serious, lasting health problems in many parts of the body.

Metabolic syndrome is more common in people with early-onset androgenic alopecia.

Pharmacists play a key role in helping patients use over-the-counter products correctly, including those for hair regrowth and smoking cessation.

Routine thyroid tests for diffuse alopecia in women may not be necessary, but checking for iron deficiency anemia could be useful.

Hormone therapy increases the risk of heart-related issues in transgender women and may affect heart health in transgender men.

Acne severity is linked to higher levels of certain androgenic hormones, even when those levels are within the normal range.

Spanlastic-laden nanogel could be a better way to deliver hair growth medication through the skin for treating hair loss.

Minoxidil and caffeine in transfersomes improve hair growth treatment.

Scalp hair grows at 0.37 mm/day, forearm hair at 0.18 mm/day, and thigh hair at 0.30 mm/day, with no significant differences found in people with certain hair conditions.

Platelet-Rich Plasma (PRP) treatment can potentially increase hair density and quality in people with hair loss, but more research is needed to confirm its effectiveness.

Platelet-Rich Plasma therapy significantly increases hair density in people with Androgenic Alopecia, and works better with more treatments per month and in younger patients.

Blood tests are needed to confirm high male hormone levels in women with PCOS, as physical signs alone are not reliable.